BRF
DMAQR

B. Riley Financial’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

B. Riley Financial’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-47,499
Closed -$6.89K – 46
2023
Q1 		$6.89K Sell
47,499
-100
-0.2% -$10 ﹤0.01% 41
2022
Q4 		$2.86K Buy
47,599
+17,500
+58% +$1K ﹤0.01% 57
2022
Q3 		$1K Buy
+30,099
New +$3.33K ﹤0.01% 73

Other funds holding DMAQR

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

B. Riley Financial's DMAQR Position: Q2 2023 in Review

B. Riley Financial sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q2 2023, closing a stake of 47,499 shares — an estimated $6.89K sold.

B. Riley Financial first reported a position in DMAQR in Q3 2022 and held it in 3 quarters. The position peaked at $6.89K in Q1 2023. 29 funds tracked by Wall St. Rank hold DMAQR as of Q2 2023.

  • B. Riley Financial reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q2 2023 after selling out during the quarter.
  • B. Riley Financial sold 47,499 Deep Medicine Acquisition Corp. Rights shares in Q2 2023, an estimated $6.89K.
  • B. Riley Financial first reported a position in Deep Medicine Acquisition Corp. Rights in Q3 2022 and held it in 3 quarters.
  • B. Riley Financial's Deep Medicine Acquisition Corp. Rights position peaked at $6.89K in Q1 2023.
  • 29 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q2 2023.

Based on B. Riley Financial's 13F filing for Q2 2023, filed 8 Aug 2023.